Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade

Mutation of isocitrate dehydrogenase indicates favorable outcomes in pan-cancer immune checkpoint blockade

Saved in:

Bibliographic Details
Main Authors:	Zhiyang Huang, Yingying Li, Hong Zhao, Bin Zhao
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	Journal of Translational Medicine
Subjects:	Isocitrate dehydrogenase Cancer Immune checkpoint blockade Biomarker
Online Access:	https://doi.org/10.1186/s12967-025-06170-6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
by: Benchao Zheng, et al.
Published: (2025-04-01)

Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
by: Jesse Haramati, et al.
Published: (2025-02-01)

Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
by: Yo-Ting Tsai, et al.
Published: (2024-03-01)

Preoperative prediction of IDH genotypes and prognosis in adult-type diffuse gliomas: intratumor heterogeneity habitat analysis using dynamic contrast-enhanced MRI and diffusion-weighted imaging
by: Xingrui Wang, et al.
Published: (2025-02-01)

Echinococcal Cyst Blockade — the Rare Cause of Acute Pancreatitis and Obstructive Jaundice
by: S. A. Budzinskiy, et al.
Published: (2023-11-01)

Prognostic value of the lactate dehydrogenase to albumin ratio in advanced non-small cell lung cancer patients treated with the first-line PD-1 checkpoint inhibitors combined with chemotherapy
by: Meifeng Luo, et al.
Published: (2025-02-01)

Differentially expressed microRNAs in pre-transplant lung biopsies target immune checkpoint proteins and can predict primary graft dysfunction in lung transplantation
by: Vitale Miceli, et al.
Published: (2025-02-01)

Understanding the Difficulties in Diagnosing Neonatal Sepsis: Assessing the Role of Sepsis Biomarkers
by: Lungu Nicoleta, et al.
Published: (2024-10-01)

Analysis of tumor-infiltrating exhausted T cells highlights IL-6 and PD1 blockade as a combined immunotherapy strategy for non-small cell lung cancer
by: Lulu Zhang, et al.
Published: (2025-02-01)

Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
by: Yiming Liu, et al.
Published: (2025-02-01)

A case of immune checkpoint inhibitor-related conjunctivitis controlled by tacrolimus eye drops
by: Ayaka Kawaguchi, et al.
Published: (2025-03-01)

Case report: A severe myositis mimicking bulbar palsy after administration of immune checkpoint inhibitors
by: Philippe Rochigneux, et al.
Published: (2025-02-01)

Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors
by: Yan Li, et al.
Published: (2025-02-01)

Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review
by: Xiuyue Man, et al.
Published: (2025-02-01)

Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
by: Yuhui Yang, et al.
Published: (2025-02-01)

The impact of PD-L1 polymorphisms on the efficacy of immune checkpoint inhibitors depends on the tumor proportion score: a retrospective study
by: Keiichiro Suminaga, et al.
Published: (2025-02-01)

Synergistic strategies for glioblastoma treatment: CRISPR-based multigene editing combined with immune checkpoint blockade
by: Xiaolin Liu, et al.
Published: (2025-02-01)

Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
by: Jeanne Shen, et al.
Published: (2024-02-01)

Free fatty acids may regulate the expression of 11β-hydroxysteroid dehydrogenase type 1 in the liver of high-fat diet golden hamsters through the ERS-CHOP-C/EBPα signaling pathway
by: Dandan Liu, et al.
Published: (2025-02-01)

VSIG4+ tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1
by: Zongfu Pan, et al.
Published: (2025-02-01)

T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy
by: Linghua Wang, et al.
Published: (2023-08-01)

Carpolobia lutea methanol root extract reinstates androgenesis and testicular function in cadmiumchallenged rats
by: Ejike, Daniel Eze, et al.
Published: (2019)

Carpolobia lutea methanol root extract reinstates androgenesis and testicular function in cadmium- challenged rats
by: Ejike, Daniel Eze, et al.
Published: (2023)

Carpolobia lutea methanol root extract reinstates androgenesis and testicular function in cadmiumchallenged rats
by: Ejike, Daniel Eze, et al.
Published: (2020)

Clinical characteristics and prognosis of amyopathic dermatomyositis patients with interstitial lung disease: insights from a retrospective cohort
by: Yanan Ying, et al.
Published: (2025-02-01)

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
by: Ruichen Gao, et al.
Published: (2025-02-01)

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
by: Yingyi Li, et al.
Published: (2025-02-01)

Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors
by: Michael Hoffmeister, et al.
Published: (2025-02-01)

CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
by: Qian Dai, et al.
Published: (2024-12-01)

Bibliometric analysis of targeted immunotherapy for osteosarcoma-current knowledge, hotspots and future perspectives
by: Yunxiang Hu, et al.
Published: (2025-02-01)

Critical evaluation of pathogenic factors of primary biliary cirrhosis
by: A. F. Sheptulina, et al.
Published: (2013-07-01)

Delving into biomarkers and predictive modeling for CVD mortality: a 20-year cohort study
by: Zhen Wu, et al.
Published: (2025-02-01)

Microbial and Inflammatory Salivary Biomarkers of Periodontal Diseases
by: Aram Mohammed Sha, et al.
Published: (2024-06-01)

Lactate Dehydrogenase-A-Forming LDH5 Promotes Breast Cancer Progression
by: Fang T, et al.
Published: (2025-02-01)

Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Cancer-Associated Venous Thrombosis: A Meta-analysis
by: Alison M. Brown, et al.
Published: (2025-01-01)

Immune monitoring of trabectedin therapy in refractory soft tissue sarcoma patients - the IMMUNYON study
by: Paulo Rodrigues-Santos, et al.
Published: (2025-02-01)

Flow cytometric characterisation of acute leukaemia in adolescent and adult Ethiopians
by: Jemal Alemu, et al.
Published: (2025-01-01)

Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders
by: Fancheng Liu, et al.
Published: (2025-02-01)

EEG alpha/beta features as a biomarker for quantifying pain in patients with lumbar disk herniation
by: Rumei Li, et al.
Published: (2025-02-01)

Six events that shaped antibody approvals in oncology
by: Suman Paul, et al.
Published: (2025-02-01)